CN1049599C - Medicine for treatment of thromboangiitis obliterans - Google Patents
Medicine for treatment of thromboangiitis obliterans Download PDFInfo
- Publication number
- CN1049599C CN1049599C CN97100779A CN97100779A CN1049599C CN 1049599 C CN1049599 C CN 1049599C CN 97100779 A CN97100779 A CN 97100779A CN 97100779 A CN97100779 A CN 97100779A CN 1049599 C CN1049599 C CN 1049599C
- Authority
- CN
- China
- Prior art keywords
- medicine
- radix
- thromboangiitis obliterans
- treatment
- realgar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a medicine for treating thromboangiitis obliterans, which belongs to a medicine preparation using natural traditional Chinese medicine materials as raw materials. The medicine is taken after raw astragalus root, platycodon root, angelica, hemlock parsley, tuckahoe, polyporus, Chinese atractylodes, dried ginger, monkshood, cassia twig, peach kernel, safflower, chilopod, dandelion, herba violae, frankincense, myrrh, realgar and raw liquorice are dried and ground into powder and are made into pills by mixing with honey. The medicine is suitable for various disease symptoms of different periods, especially for long-term application of obstinate diseases. The effective rate reaches 96.82%.
Description
The present invention relates to the natural Chinese medicine is the pharmaceutical product of raw material, particularly a kind of medicine for the treatment of thromboangiitis obliterans.
Thromboangiitis obliterans is a kind of chronic general vascular disorder, and its etiology is still not fully aware of, does not have specific treatment yet.Usually adopting surgical operation is lumbar sympathectomy or physiotherapy; Drug therapy often adopts vasodilator.Above-mentioned treatment curative effect is very not remarkable, and dialectical the executing of Chinese medicine controlled typing, adopts different side's medicines to obtain satisfactory effect.
" journal of shanghai Chinese medicine " 19922 " thromboangiitis obliterans progress " report: asthenic cold type is with YANGHE TANG or decoction for Resuscitation; QI and blood stasis type usefulnessization silt soup; Damp-heat type removing dampness Eradicates numbness soup; The heat-toxin type SIMIAOYONGAN TANG.Many doctor's typings difference side medicine is different.
" new the traditional Chinese medical science " 19845 " thromboangiitis obliterans is controlled to test and plucked Jie " disclose the proved recipe of controlling of Dengxian county, Henan Province institute of traditional Chinese medicine, Hebei province's Tangshan Area, Harbin City, Heilongjiang Province city institute of traditional Chinese medicine respectively.As basic side's Radix Angelicae Sinensis, each 15 gram of the Radix Astragali, Radix Codonopsis, Radix Paeoniae Rubra, Radix Achyranthis Bidentatae, Semen Persicae, Pheretima, each 9 gram of Hirudo, Rhizoma Chuanxiong, each 6 gram of Flos Carthami.Heat-toxin type is drunk and is added Flos Lonicerae, Herba Taraxaci, each 15 gram of Radix Scrophulariae; The YIN-cold type is drunk and is added Radix Aconiti Lateralis Preparata, each 9 gram of Rhizoma Zingiberis, Ramulus Cinnamomi 15 grams; Cooler person of convalescent period adds Ramulus Cinnamomi, each 15 gram of Radix Rehmanniae Preparata; Partial heat person is with Radix Scrophulariae, each 15 gram of the Radix Rehmanniae or the like.
Purpose of the present invention is exactly to be applicable to that in order to provide a kind of dissimilar thromboangiitis obliterans patients of each phase use, especially the medicine of the treatment thromboangiitis obliterans of obstinate disease prolonged application.
The present invention is the principal agent dispelling cold by warming the meridian with Radix Aconiti Lateralis Preparata, Rhizoma Zingiberis, Ramulus Cinnamomi is walked extremity partially to increase its effect, the Scolopendra power of stimulating the menstrual flow is the strongest, Semen Persicae, Flos Carthami are controlled blood Eradicates and are become silted up, the promoting the circulation of blood of enriching blood of Rhizoma Chuanxiong and Radix Angelicae Sinensis compatibility, Poria, the sharp skin of Polyporus eliminating dampness by diuresis, it is strong that Herba Taraxaci, Herba Violae are separated virulence, Olibanum, Myrrha, Realgar Eradicates corruption, granulation promoting, pain relieving more improve body immunity with the Radix Astragali, Poria, Rhizoma Atractylodis spleen invigorating QI invigorating.
The present invention is processed by following weight portion medical material combination:
Radix Astragali 15-30, Radix Platycodonis 15-30, Radix Angelicae Sinensis 10-15, Rhizoma Chuanxiong 10-15,
Poria 10-15, Polyporus 15-20, Rhizoma Atractylodis 10-15, Rhizoma Zingiberis 15-20,
Radix Aconiti Lateralis Preparata 6-10, Ramulus Cinnamomi 10-15, Semen Persicae 10-15, Flos Carthami 10-15,
Herba Taraxaci 10-15, Scolopendra 3-6, Herba Violae 10-15, Olibanum 5-10,
Radix Glycyrrhizae 10-15, Myrrha 5-10, Realgar 1-2.
The ideal weight portion proportioning of preparation pharmaceutical formulation of the present invention is:
Radix Astragali 15, Radix Platycodonis 15, Radix Angelicae Sinensis 12, Rhizoma Chuanxiong 12, Poria 10, Polyporus 15,
Rhizoma Atractylodis 10, Rhizoma Zingiberis 15, Radix Aconiti Lateralis Preparata 6, Ramulus Cinnamomi 10, Semen Persicae 10, Flos Carthami 10,
Herba Taraxaci 10, Scolopendra 6, Herba Violae 10, Olibanum 6, Myrrha 6, Realgar 1.5,
Radix Glycyrrhizae 10.
The method that above-mentioned each component Chinese crude drug is made medicine of the present invention is:
Above-mentioned medical material after 24 hours, was pulverized 80 mesh sieves through 80 ℃ of drying and sterilizings of far-infrared rays drying case, radiosterilization, making pellets by mixing medical powder with honey, every ball 9 grams are gone into to mould shell and are sealed with wax, pack, and every box ten balls are standby.
Drug dose of the present invention and instructions of taking: oral medicine of the present invention every day 2 times, each 2 balls, warm water delivery service, one month is a course of treatment.
Through using clinical drug of the present invention to treat 126 routine patients, clinical cure 42 examples account for 33.33% after three courses of treatment; Produce effects 58 examples account for 46.03%; 22 examples that take a turn for the better account for 17.46%; Invalid 4 examples account for 3.18%; Total effective rate is 96.82%.See attached list.
The curative effect statistical annex
| Classification | Treatment | Produce effects | Take a turn for the better | Invalid | Add up to | ||||
| The example number | ％ | The example number | ％ | The example number | ％ | The example number | ％ | ||
| Phlebitis | 23 | 18.2 | 34 | 26.9 | 9 | 7.1 | 1 | 0.7 | 67 |
| Arteritis | 19 | 15.1 | 24 | 19 | 13 | 10.3 | 3 | 2.3 | 59 |
| Subtotal | 42 | 33.33 | 58 | 46.03 | 22 | 17.46 | 4 | 3.18 | 126 |
Embodiment:
Take by weighing Radix Astragali 15kg, Radix Platycodonis 15kg, Radix Angelicae Sinensis 12kg, Rhizoma Chuanxiong 12kg, Poria 10kg, Polyporus 15kg, Rhizoma Atractylodis 10kg, Rhizoma Zingiberis 15kg, Radix Aconiti Lateralis Preparata 6kg, Ramulus Cinnamomi 10kg, Semen Persicae 10kg, Flos Carthami 10kg, Scolopendra 6kg, Herba Taraxaci 10kg, Herba Violae 10kg, Olibanum 6kg, Myrrha 6kg, Realgar 1.5kg, Radix Glycyrrhizae 10kg.Put into 80 ℃ of drying and sterilizings of far infrared drying case respectively 24 hours, and removed moisture content and the about 19.85kg of airborne dust, can dry medical material 178.65kg, cross 80 mesh sieves after the mechanical activation comminution, adopt cobalt 60 radiosterilizations sterilization mix homogeneously standby.Take by weighing Mel 196.52kg and be cut into shape, go into to mould box and seal, can get 41547 of pills approximately through wax with the above agglomerating bar that is squeezed into of medicated powder stirring that mixes the back, every box ten balls, but packing 4154 boxes, honey is 1.1: 1 with the medicine mixed proportion, every ball weighs 9 grams, its Chinese medicine 4.3 grams, honey 4.7 grams.
This medicine property of medicine gentleness, safety, curative effect height, toxic and side effects is not found in clinical use, total effective rate reaches 96.82%, but is thromboangiitis obliterans patient drug of choice thing.
Claims (2)
1. medicine for the treatment of thromboangiitis obliterans is characterized in that this medicine is that drug regimen by following weight parts forms:
Radix Astragali 15-30, Radix Platycodonis 15-30, Radix Angelicae Sinensis 10-15, Rhizoma Chuanxiong 10-15,
Poria 10-15, Polyporus 15-20, Rhizoma Atractylodis 10-15, Rhizoma Zingiberis 15-20, attached
Sub-6-10, Ramulus Cinnamomi 10-15, Semen Persicae 10-15, Flos Carthami 10-15, Scolopendra
3-6, Herba Taraxaci 10-15, Herba Violae 10-15, Olibanum 5-10, Myrrha 5
-10, Realgar 1-2, Radix Glycyrrhizae 10-15.
2. the medicine of treatment thromboangiitis obliterans according to claim 1 is characterized in that the ideal weight portion proportioning of medicine of the present invention is:
Radix Astragali 15, Radix Platycodonis 15, Radix Angelicae Sinensis 12, Rhizoma Chuanxiong 12, Poria 10, Polyporus 15, grey
Art 10, Rhizoma Zingiberis 15, Radix Aconiti Lateralis Preparata 6, Ramulus Cinnamomi 10, Semen Persicae 10, Flos Carthami 10, Scolopendra 6,
Herba Taraxaci 10, Herba Violae 10, Olibanum 6, Myrrha 6, Realgar 1.5, Radix Glycyrrhizae 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97100779A CN1049599C (en) | 1997-02-27 | 1997-02-27 | Medicine for treatment of thromboangiitis obliterans |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97100779A CN1049599C (en) | 1997-02-27 | 1997-02-27 | Medicine for treatment of thromboangiitis obliterans |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1159943A CN1159943A (en) | 1997-09-24 |
| CN1049599C true CN1049599C (en) | 2000-02-23 |
Family
ID=5165313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97100779A Expired - Fee Related CN1049599C (en) | 1997-02-27 | 1997-02-27 | Medicine for treatment of thromboangiitis obliterans |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1049599C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103007113A (en) * | 2013-01-11 | 2013-04-03 | 来玉民 | Traditional Chinese medicinal composition for treating phlebitis and method for preparing same |
-
1997
- 1997-02-27 CN CN97100779A patent/CN1049599C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 中医药学报1995(3) 1995.1.1 薛广成等，中药内外兼治血栓闭塞性脉管炎100例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1159943A (en) | 1997-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101095845A (en) | Century health preserving magical wine | |
| CN101422591A (en) | Capsules capable of greatly improving immunity and preparation method thereof | |
| CN1278446A (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN101897879A (en) | Traditional Chinese medicine for treating rheumatic arthritis | |
| CN1049827C (en) | Anti-cancer powder | |
| CN101239134B (en) | Speckle-removing medicinal composition | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN102038751A (en) | Traditional Chinese medicine formulation for treating infantile diarrhea | |
| CN101336998B (en) | Traditional Chinese medicine for treating whelk | |
| CN101214365A (en) | Chinese medicine composing prescription for treating mastoproliferation | |
| CN1049599C (en) | Medicine for treatment of thromboangiitis obliterans | |
| CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
| CN102018815A (en) | Chinese medicine preparation for treating tuberculosis of lumbar spine | |
| CN104971318A (en) | Traditional Chinese medicine preparation for treating cholelithiasis | |
| CN105169279A (en) | Traditional Chinese medicine composition for treating knee joint bone hyperplasia | |
| CN101843825B (en) | Chinese medicament for treating climacteric syndromes | |
| CN101912566B (en) | Traditional Chinese medicine for treating palpitation | |
| Xu et al. | Chinese herbal medicine | |
| CN101874851B (en) | Traditional Chinese medicine for treating chronic infectious arthritis | |
| CN104826043A (en) | Chinese medicinal formula for treating crural sprain | |
| CN102847078A (en) | Chinese medicinal composition for treating chronic enteritis (due to insufficiency of both the spleen and the kidney) | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN104107266A (en) | Bone-strengthening tablet | |
| CN103505531A (en) | Traditional Chinese medicine formula for preventing and treating spondylodynia | |
| CN102755378B (en) | Traditional Chinese medicine composition for preventing and treating osteoporosis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |